Christophe Queva - CSO and SVP, Oncorus, Inc
As of June 3, 2021
Christophe Queva Net Worth
- Net worth is estimated to be at least $1.39M
- Owns at least 47,626 units of Oncorus, Inc stock
- Sold an estimated value of $1.13M in the last year at Oncorus, Inc
Christophe Queva Trading
- Largest sale of shares was 23,555 units , worth over $392.81K on June 3, 2021
- In total has made about 7 transactions over a year
- Usually trades in May and April, with the busiest year in 2021
Christophe Queva
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Christophe Queva Mailing Address
- Mailing address is C/o Oncorus, Inc. 50 Hampshire Street, Suite 401 Cambridge MA 02139 MA
Oncorus, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Theodore (Ted) Ashburn, M.D., Ph.D. Theodore (Ted) Ashburn, M.D., Ph.D. | 2020 20192019 | $448,607 408,000408,000 | $75,000 | $1,357,701 1,227,5311,227,531 | $202,611 135,660135,660 | $33,910 29,91329,913 | $2,117,829 1,801,1041,801,104 |
| Theodore (Ted) Ashburn, M.D., Ph.D. Theodore (Ted) Ashburn, M.D., Ph.D. | 2020 | $370,917 | - | $962,058 | $142,728 | $31,937 | $1,507,640 |
| Theodore (Ted) Ashburn, M.D., Ph.D. Theodore (Ted) Ashburn, M.D., Ph.D. | 2019 | $340,100 | - | $443,540 | $96,929 | $28,489 | $909,058 |
| Theodore (Ted) Ashburn, M.D., Ph.D. Theodore (Ted) Ashburn, M.D., Ph.D. | 2020 | $67,178 | - | $5,606,802 | $6,970 | $1,982 | $5,682,932 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1671818/000119312521136848/d28828ddef14a.htm
Oncorus, Inc Insider Trading
- The most recent transaction was 30,000 units bought on November 17, 2021 by Stephen Harbin worth over $173.66K
- In the last year, insiders at Oncorus, Inc sold an estimated value of $1.13M and bought an estimated value of $35.73M
- The most active traders are Christophe Queva, CSO and SVP, Theodore Ashburn, President and CEO, and Stephen Harbin, COO and Chief Staff
- Insider trading is most common in October, with the busiest year in 2021
Oncorus, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||